[144] TG Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

TG Therapeutics (TGTX) notice of proposed sale reports an insider intends to sell 20,852 common shares through Fidelity Brokerage Services on NASDAQ with an aggregate market value of $672,232.59. These shares represent approximately 0.013% of the reported 158,665,613 shares outstanding and were acquired on 06/22/2023 by restricted stock vesting as compensation.

The filing lists no securities sold in the past three months and specifies the proposed sale date as 09/11/2025. The filer affirms they are not aware of any undisclosed material adverse information about the issuer. This is a routine Rule 144 disclosure showing a planned disposition of vested equity awarded as compensation.

Positive

• Transparent disclosure of an insider sale pursuant to Rule 144 through Fidelity Brokerage Services
• Securities were acquired via restricted stock vesting, indicating the shares originated from compensation rather than an open-market purchase
• No other sales in the past three months reported for the selling person

Negative

• None.

Insights

Securities Analyst

TL;DR: Small, routine Rule 144 sale by an insider; size is immaterial relative to outstanding shares.

The filing documents a planned sale of 20,852 shares valued at $672,232.59, acquired via restricted stock vesting on 06/22/2023. At roughly 0.013% of the companys stated outstanding shares, this transaction is unlikely to move market prices or significantly change ownership structure. The absence of other sales in the past three months and the filers statement about no undisclosed material information are consistent with routine insider liquidity events.

Corporate Governance Expert

TL;DR: Filing shows standard compliance with disclosure rules; reflects transparency on insider compensation monetization.

The notice indicates the securities were awarded as compensation and vested on 06/22/2023, with the sale to be executed through Fidelity. Filing under Rule 144 notifies the market of an intended sale and helps maintain orderly disclosure. There are no indications in the form of accelerated sales, aggregated sales disclosures, or other governance red flags within the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	20852	672232.59	158665613	09/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/22/2023	Restricted Stock Vesting	Issuer			20852	06/22/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for TGTX report?

The form reports a proposed sale of 20,852 common shares valued at $672,232.59 to be sold on 09/11/2025 through Fidelity on NASDAQ.

How were the shares acquired according to the filing?

The filing states the shares were acquired on 06/22/2023 through restricted stock vesting and were received as compensation.

What percentage of outstanding TGTX shares does this proposed sale represent?

The filing lists 158,665,613 shares outstanding; the proposed sale of 20,852 equals about 0.013% of outstanding shares.

Has the filer sold other TGTX securities in the past three months?

The form states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Through which broker will the sale be executed?

The notice names Fidelity Brokerage Services LLC as the broker handling the proposed sale.